Annual Cash & Cash Equivalents
$5.84 M
-$5.65 M-49.20%
31 December 2023
Summary:
Imunon annual cash & cash equivalents is currently $5.84 million, with the most recent change of -$5.65 million (-49.20%) on 31 December 2023. During the last 3 years, it has fallen by -$11.33 million (-65.98%). IMNN annual cash & cash equivalents is now -71.02% below its all-time high of $20.15 million, reached on 01 December 2011.IMNN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$10.31 M
+$5.01 M+94.32%
30 September 2024
Summary:
Imunon quarterly cash and cash equivalents is currently $10.31 million, with the most recent change of +$5.01 million (+94.32%) on 30 September 2024. Over the past year, it has dropped by -$2.57 million (-19.96%). IMNN quarterly cash and cash equivalents is now -72.69% below its all-time high of $37.76 million, reached on 01 March 2021.IMNN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.2% | -20.0% |
| 3 y3 years | -66.0% | -59.8% |
| 5 y5 years | -56.3% | +21.0% |
IMNN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.2% | at low | -63.6% | +339.4% |
| 5 y | 5 years | -70.2% | at low | -72.7% | +339.4% |
| alltime | all time | -71.0% | >+9999.0% | -72.7% | +3516.9% |
Imunon Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.31 M(+94.3%) |
| June 2024 | - | $5.31 M(+126.1%) |
| Mar 2024 | - | $2.35 M(-59.8%) |
| Dec 2023 | $5.84 M(-49.2%) | $5.84 M(-54.7%) |
| Sept 2023 | - | $12.88 M(+94.9%) |
| June 2023 | - | $6.61 M(-36.4%) |
| Mar 2023 | - | $10.40 M(-9.5%) |
| Dec 2022 | $11.49 M(-41.3%) | $11.49 M(-57.3%) |
| Sept 2022 | - | $26.94 M(+0.7%) |
| June 2022 | - | $26.74 M(-5.7%) |
| Mar 2022 | - | $28.36 M(+44.8%) |
| Dec 2021 | $19.59 M(+14.1%) | - |
| Dec 2021 | - | $19.59 M(-23.6%) |
| Sept 2021 | - | $25.65 M(-3.0%) |
| June 2021 | - | $26.44 M(-30.0%) |
| Mar 2021 | - | $37.76 M(+120.0%) |
| Dec 2020 | $17.16 M(+149.7%) | $17.16 M(-6.4%) |
| Sept 2020 | - | $18.34 M(-19.0%) |
| June 2020 | - | $22.65 M(+294.2%) |
| Mar 2020 | - | $5.75 M(-16.4%) |
| Dec 2019 | $6.88 M(-48.5%) | $6.88 M(-19.3%) |
| Sept 2019 | - | $8.52 M(+41.7%) |
| June 2019 | - | $6.01 M(+68.2%) |
| Mar 2019 | - | $3.58 M(-73.2%) |
| Dec 2018 | $13.35 M(+16.7%) | $13.35 M(+296.1%) |
| Sept 2018 | - | $3.37 M(-73.6%) |
| June 2018 | - | $12.75 M(+458.1%) |
| Mar 2018 | - | $2.29 M(-80.0%) |
| Dec 2017 | $11.44 M(+336.1%) | $11.44 M(+326.2%) |
| Sept 2017 | - | $2.69 M(-26.0%) |
| June 2017 | - | $3.63 M(-18.8%) |
| Mar 2017 | - | $4.47 M(+70.3%) |
| Dec 2016 | $2.62 M(-71.7%) | $2.62 M(-37.3%) |
| Sept 2016 | - | $4.18 M(-66.0%) |
| June 2016 | - | $12.31 M(-14.0%) |
| Mar 2016 | - | $14.31 M(+54.5%) |
| Dec 2015 | $9.27 M(-27.0%) | $9.27 M(+22.3%) |
| Sept 2015 | - | $7.57 M(-36.6%) |
| June 2015 | - | $11.95 M(+57.0%) |
| Mar 2015 | - | $7.61 M(-40.0%) |
| Dec 2014 | $12.69 M(+121.9%) | $12.69 M(+178.3%) |
| Sept 2014 | - | $4.56 M(-52.5%) |
| June 2014 | - | $9.60 M(+108.4%) |
| Mar 2014 | - | $4.61 M(-19.4%) |
| Dec 2013 | $5.72 M(-61.9%) | $5.72 M(-56.6%) |
| Sept 2013 | - | $13.17 M(+118.8%) |
| June 2013 | - | $6.02 M(-70.4%) |
| Mar 2013 | - | $20.37 M(+35.9%) |
| Dec 2012 | $14.99 M(-25.6%) | $14.99 M(+80.2%) |
| Sept 2012 | - | $8.32 M(-29.0%) |
| June 2012 | - | $11.71 M(+28.3%) |
| Mar 2012 | - | $9.12 M(-54.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $20.15 M(+1668.9%) | $20.15 M(+81.0%) |
| Sept 2011 | - | $11.13 M(+106.9%) |
| June 2011 | - | $5.38 M(+173.9%) |
| Mar 2011 | - | $1.96 M(+72.5%) |
| Dec 2010 | $1.14 M(-83.6%) | $1.14 M(-37.6%) |
| Sept 2010 | - | $1.82 M(-33.5%) |
| June 2010 | - | $2.75 M(-33.3%) |
| Mar 2010 | - | $4.11 M(-40.6%) |
| Dec 2009 | $6.92 M(+100.3%) | $6.92 M(-42.8%) |
| Sept 2009 | - | $12.10 M(-0.1%) |
| June 2009 | - | $12.11 M(+530.9%) |
| Mar 2009 | - | $1.92 M(-44.4%) |
| Dec 2008 | $3.46 M(+17.7%) | $3.46 M(+322.4%) |
| Sept 2008 | - | $818.30 K(-21.2%) |
| June 2008 | - | $1.04 M(-32.7%) |
| Mar 2008 | - | $1.54 M(-47.5%) |
| Dec 2007 | $2.94 M(+184.4%) | $2.94 M(+23.1%) |
| Sept 2007 | - | $2.39 M(+0.9%) |
| June 2007 | - | $2.36 M(+328.0%) |
| Mar 2007 | - | $552.40 K(-46.5%) |
| Dec 2006 | $1.03 M(-55.4%) | $1.03 M(-44.9%) |
| Sept 2006 | - | $1.87 M(+556.9%) |
| June 2006 | - | $285.10 K(-73.3%) |
| Mar 2006 | - | $1.07 M(-53.8%) |
| Dec 2005 | $2.31 M(+294.5%) | $2.31 M(-75.0%) |
| Sept 2005 | - | $9.25 M(+74.1%) |
| June 2005 | - | $5.32 M(-29.4%) |
| Mar 2005 | - | $7.53 M(+1184.8%) |
| Dec 2004 | $586.40 K(-95.2%) | $586.40 K(-95.8%) |
| Sept 2004 | - | $13.95 M(-21.5%) |
| June 2004 | - | $17.78 M(-8.5%) |
| Mar 2004 | - | $19.43 M(+58.3%) |
| Dec 2003 | - | $12.27 M(0.0%) |
| Sept 2003 | $12.27 M(+1221.3%) | $12.27 M(+123.1%) |
| June 2003 | - | $5.50 M(+74.8%) |
| Mar 2003 | - | $3.15 M(+199.6%) |
| Dec 2002 | - | $1.05 M(+13.1%) |
| Sept 2002 | $928.80 K(-63.0%) | $928.80 K(-70.2%) |
| June 2002 | - | $3.12 M(-11.6%) |
| Mar 2002 | - | $3.53 M(-18.6%) |
| Dec 2001 | - | $4.34 M(+72.7%) |
| Sept 2001 | $2.51 M(-71.5%) | $2.51 M(-45.8%) |
| June 2001 | - | $4.63 M(-24.5%) |
| Mar 2001 | - | $6.13 M(-18.0%) |
| Dec 2000 | - | $7.48 M(-15.2%) |
| Sept 2000 | $8.82 M(+530.0%) | $8.82 M(-12.6%) |
| June 2000 | - | $10.09 M(+4.9%) |
| Mar 2000 | - | $9.62 M(+1102.4%) |
| Dec 1999 | - | $800.00 K(-42.9%) |
| Sept 1999 | $1.40 M(+2450.1%) | $1.40 M |
| Sept 1998 | $54.90 K(-79.5%) | - |
| Sept 1997 | $267.40 K(+8.3%) | - |
| Sept 1996 | $246.90 K | - |
FAQ
- What is Imunon annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Imunon?
- What is Imunon annual cash & cash equivalents year-on-year change?
- What is Imunon quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Imunon?
- What is Imunon quarterly cash and cash equivalents year-on-year change?
What is Imunon annual cash & cash equivalents?
The current annual cash & cash equivalents of IMNN is $5.84 M
What is the all time high annual cash & cash equivalents for Imunon?
Imunon all-time high annual cash & cash equivalents is $20.15 M
What is Imunon annual cash & cash equivalents year-on-year change?
Over the past year, IMNN annual cash & cash equivalents has changed by -$5.65 M (-49.20%)
What is Imunon quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMNN is $10.31 M
What is the all time high quarterly cash and cash equivalents for Imunon?
Imunon all-time high quarterly cash and cash equivalents is $37.76 M
What is Imunon quarterly cash and cash equivalents year-on-year change?
Over the past year, IMNN quarterly cash and cash equivalents has changed by -$2.57 M (-19.96%)